BIO
Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
Bio-Rad Laboratories, Inc. (BIO) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B+); its weakest is Growth (C-). The rating has held at C+ for 5 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-16 | B- (2.9) | C- (1.9) | B (3.2) | B+ (3.7) | C- (2.1) | C+ (2.8) |
| 2026-11-09 | C+ (2.8) | C- (1.9) | B (3.2) | B+ (3.7) | C- (2.1) | C+ (2.7) |
| 2026-11-06 | C+ (2.5) | C- (1.9) | B (3.2) | B+ (3.7) | C- (2.1) | C+ (2.7) |
| 2026-11-05 | C+ (2.5) | C- (2.0) | B (3.2) | B+ (3.6) | C (2.3) | C+ (2.7) |
| 2026-11-02 | C+ (2.5) | C- (1.9) | B (3.2) | B+ (3.5) | C- (1.9) | C+ (2.6) |